Logo image of LGMK

LOGICMARK INC (LGMK) Stock Fundamental Analysis

NASDAQ:LGMK - US67091J6029 - Common Stock

0.0115 USD
0 (-5.74%)
Last: 5/30/2025, 8:11:29 PM
0.0063 USD
-0.01 (-45.22%)
After Hours: 5/30/2025, 8:11:29 PM
Fundamental Rating

2

Taking everything into account, LGMK scores 2 out of 10 in our fundamental rating. LGMK was compared to 187 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for LGMK as it has an excellent financial health rating, but there are worries on the profitability. LGMK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LGMK had negative earnings in the past year.
LGMK had a negative operating cash flow in the past year.
In the past 5 years LGMK always reported negative net income.
In the past 5 years LGMK always reported negative operating cash flow.
LGMK Yearly Net Income VS EBIT VS OCF VS FCFLGMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -38.67%, LGMK is not doing good in the industry: 63.83% of the companies in the same industry are doing better.
With a Return On Equity value of -42.37%, LGMK perfoms like the industry average, outperforming 51.06% of the companies in the same industry.
Industry RankSector Rank
ROA -38.67%
ROE -42.37%
ROIC N/A
ROA(3y)-62.15%
ROA(5y)-49.38%
ROE(3y)-71.32%
ROE(5y)-59.48%
ROIC(3y)N/A
ROIC(5y)N/A
LGMK Yearly ROA, ROE, ROICLGMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

LGMK has a better Gross Margin (65.71%) than 69.15% of its industry peers.
LGMK's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for LGMK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y-2.16%
LGMK Yearly Profit, Operating, Gross MarginsLGMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

7

2. Health

2.1 Basic Checks

LGMK does not have a ROIC to compare to the WACC, probably because it is not profitable.
LGMK has more shares outstanding than it did 1 year ago.
LGMK has more shares outstanding than it did 5 years ago.
There is no outstanding debt for LGMK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LGMK Yearly Shares OutstandingLGMK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
LGMK Yearly Total Debt VS Total AssetsLGMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

LGMK has an Altman-Z score of -4.38. This is a bad value and indicates that LGMK is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LGMK (-4.38) is worse than 69.68% of its industry peers.
LGMK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.38
ROIC/WACCN/A
WACC9.05%
LGMK Yearly LT Debt VS Equity VS FCFLGMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

LGMK has a Current Ratio of 7.56. This indicates that LGMK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 7.56, LGMK belongs to the top of the industry, outperforming 87.77% of the companies in the same industry.
LGMK has a Quick Ratio of 7.25. This indicates that LGMK is financially healthy and has no problem in meeting its short term obligations.
LGMK has a better Quick ratio (7.25) than 88.30% of its industry peers.
Industry RankSector Rank
Current Ratio 7.56
Quick Ratio 7.25
LGMK Yearly Current Assets VS Current LiabilitesLGMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

0

3. Growth

3.1 Past

LGMK shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.31%.
The Revenue has been growing slightly by 1.56% in the past year.
The Revenue for LGMK have been decreasing by -10.39% on average. This is quite bad
EPS 1Y (TTM)-4.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.44%
Revenue 1Y (TTM)1.56%
Revenue growth 3Y-0.4%
Revenue growth 5Y-10.39%
Sales Q2Q%-0.73%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.79%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.72%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LGMK Yearly Revenue VS EstimatesLGMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
LGMK Yearly EPS VS EstimatesLGMK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2023 2024 2025 -5K -10K -15K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LGMK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LGMK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGMK Price Earnings VS Forward Price EarningsLGMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LGMK Per share dataLGMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LGMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LOGICMARK INC

NASDAQ:LGMK (5/30/2025, 8:11:29 PM)

After market: 0.0063 -0.01 (-45.22%)

0.0115

0 (-5.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-15 2025-05-15/dmh
Earnings (Next)08-11 2025-08-11
Inst Owners2.62%
Inst Owner Change-8.37%
Ins Owners0.03%
Ins Owner Change0%
Market Cap6.63M
Analysts43.33
Price Target0.26 (2160.87%)
Short Float %0.15%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.13
Dividend Growth(5Y)N/A
DP-3.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-649%
Min EPS beat(2)-1005.85%
Max EPS beat(2)-292.16%
EPS beat(4)2
Avg EPS beat(4)-307.89%
Min EPS beat(4)-1005.85%
Max EPS beat(4)54.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.24%
Min Revenue beat(2)-3.25%
Max Revenue beat(2)-1.22%
Revenue beat(4)1
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)8.78%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-93.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-100%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.67
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)-42.43
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.02
BVpS0.04
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.67%
ROE -42.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.71%
FCFM N/A
ROA(3y)-62.15%
ROA(5y)-49.38%
ROE(3y)-71.32%
ROE(5y)-59.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y-2.16%
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.56
Quick Ratio 7.25
Altman-Z -4.38
F-Score4
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)13.92%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.44%
EPS Next Y99.79%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.56%
Revenue growth 3Y-0.4%
Revenue growth 5Y-10.39%
Sales Q2Q%-0.73%
Revenue Next Year0.72%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.88%
OCF growth 3YN/A
OCF growth 5YN/A